Brief: Pfizer Submitted Its Sweetened Bid To Buy Metsera, Which Matches Novo’S Offer Valuing Metsera At $86.20 A Share - FT

Nov 5 (Reuters) -

PFIZER SUBMITTED ITS SWEETENED BID TO BUY METSERA, WHICH MATCHES NOVO’S OFFER  VALUING METSERA AT $86.20 A SHARE - FT

Source text: https://tinyurl.com/3a5ywse7

Further company coverage: MTSR.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Metsera

See all news